Sort
15,273 grants matching “antimicrobial resistance”
Small-Molecule Antibiotics Targeting Siderophore Biosynthesis in M. tuberculosis
$666,740Derek S Tan · Sloan-Kettering Inst Can Research · R01 · FY2017 · AI
Small-Molecule Antibiotics Targeting Siderophore Biosynthesis in M. tuberculosis
$666,740Derek S Tan · Sloan-Kettering Inst Can Research · R01 · FY2020 · AI
Clinical factors in aminoglycoside-induced ototoxicity
$666,714Peter S Steyger · Creighton University · R01 · FY2022 · DC
Syphilis immunology and biology to improve clinical management and vaccine design
$666,190Jeffrey David Klausner · University Of California Los Angeles · R01 · FY2018 · AI
Clinical factors in aminoglycoside-induced ototoxicity
$666,142Peter S Steyger · Creighton University · R01 · FY2020 · DC
Clinical factors in aminoglycoside-induced ototoxicity
$666,142Peter S Steyger · Creighton University · R01 · FY2021 · DC
ID. of Pathways that can be Targeted for the Develop. of Novel Therapies for MRSA
$665,993Eleftherios Mylonakis · Massachusetts Eye And Ear Infirmary · P01 · FY2012 · AI
Emerging antibiotic resistance in Gram-negative pathogens
$665,756Edward W Yu · Case Western Reserve University · R01 · FY2020 · AI
Differential Inflammasome Regulation in the pathogenesis of S. aureus osteomyelitis
$665,686Deborah V Novack · Washington University · R01 · FY2025 · AI
Molecular Insights into the Uropathogenesis of MDR Acinetobacter baumannii
$665,586Mario Feldman · Washington University · R01 · FY2020 · AI
Role of epithelial ROS signaling in mediating psychological stress-induced mucosal dysfunction and colitis predisposition
$665,574Jacob Matthew Allen · University Of Illinois At Urbana-Champaign · R01 · FY2023 · DK
Evolution, transmission, and control of drug-resistant tuberculosis
$665,566Theodore H Cohen · Yale University · R01 · FY2025 · AI
Microbial Ecology-Guided Discovery of Antibacterial Drugs
$664,819Eric W Schmidt · University Of Utah · R01 · FY2022 · AI
Antimicrobial evaluation and development
$664,543Kim Lewis · Northeastern University · P01 · FY2020 · AI
Transferrin Combination Therapy to Address Antimicrobial Resistance
$664,299Brad J Spellberg · University Of Southern California · R01 · FY2016 · AI
Functional Genomics Core
$664,117Anthony Haag · Methodist Hospital Research Institute · P01 · FY2024 · AI
Oral microbiome and inflammatory status in antimicrobially-treated oral cancer patients
$664,088Yvonne L Kapila · University Of California Los Angeles · R01 · FY2022 · CA
Mycobacterial DNA repair and mutagenesis
$663,906Michael Stephen Glickman · Sloan-Kettering Inst Can Research · R01 · FY2022 · AI
Mycobacterial DNA repair and mutagenesis
$663,906Michael Stephen Glickman · Sloan-Kettering Inst Can Research · R01 · FY2021 · AI
Mycobacterial DNA repair and mutagenesis
$663,906Michael Stephen Glickman · Sloan-Kettering Inst Can Research · R01 · FY2023 · AI
Mycobacterial DNA repair and mutagenesis
$663,906Michael Stephen Glickman · Sloan-Kettering Inst Can Research · R01 · FY2024 · AI
Mycobacterial DNA repair and mutagenesis
$663,906Michael Stephen Glickman · Sloan-Kettering Inst Can Research · R01 · FY2020 · AI
A Rapid Assay for RNA Targeted Drugs
$663,747Dev Priya Arya · Nubad, Llc · R42 · FY2015 · GM
Improving perinatal outcomes among Kenyan pregnant women affected by HIV with an integrated STI testing model
$662,753Jillian Pintye · University Of Washington · R01 · FY2024 · HD
The roles of genes critical for growth in vitro
$662,658Dirk Schnappinger · Harvard School Of Public Health · U19 · FY2014 · AI